{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:02:38Z","timestamp":1770742958647,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["2016-ER6304-02"],"award-info":[{"award-number":["2016-ER6304-02"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00380-023-02244-x","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T15:02:46Z","timestamp":1676559766000},"page":"898-908","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in elderly (\u2265\u200965) patients with acute myocardial infarction without hypertension"],"prefix":"10.1007","volume":"38","author":[{"given":"Woo Jin","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9456-9852","authenticated-orcid":false,"given":"Seung-Woon","family":"Rha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung Geol","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"and Other Korea Acute Myocardial Infarction Registry (KAMIR)-National Institutes of Health (NIH) Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junghan","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo\u2010Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki\u2010Bae","family":"Seung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon\u2010Cheol","family":"Gwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shung Chull","family":"Chae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong\u2010Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang Soo","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung\u2010Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jei Keon","family":"Chae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung\u2010Jae","family":"Joo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang\u2010Hwan","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung\u2010Ho","family":"Hur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u2010Whan","family":"Seong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung\u2010Kuk","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doo\u2010Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Kyu","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin\u2010Yong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"2244_CR1","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1136\/hrt.2009.188607","volume":"96","author":"P Bramlage","year":"2010","unstructured":"Bramlage P, Messer C, Bitterlich N, Pohlmann C, Cuneo A, Stammwitz E, Tebbenjohanns J, Gohlke H, Senges J, Tebbe U (2010) The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction. Heart 96:604\u2013609","journal-title":"Heart"},{"key":"2244_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/2047487318808638","volume":"26","author":"V Tea","year":"2019","unstructured":"Tea V, Bonaca M, Chamandi C, Iliou MC, Lhermusier T, Aissaoui N, Cayla G, Angoulvant D, Ferrieres J, Schiele F, Simon T, Danchin N, Puymirat E, investigators F-M, (2019) Appropriate secondary prevention and clinical outcomes after acute myocardial infarction according to atherothrombotic risk stratification: the FAST-MI 2010 registry. Eur J Prev Cardiol 26:411\u2013419","journal-title":"Eur J Prev Cardiol"},{"key":"2244_CR3","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1161\/CIRCULATIONAHA.116.025950","volume":"135","author":"FH Messerli","year":"2017","unstructured":"Messerli FH, Bangalore S (2017) Angiotensin receptor blockers reduce cardiovascular events, including the risk of myocardial infarction. Circulation 135:2085\u20132087","journal-title":"Circulation"},{"key":"2244_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsky P, Group ESCSD (2018) 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39:119\u2013177","journal-title":"Eur Heart J"},{"key":"2244_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S (2016) 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 37:267\u2013315","journal-title":"Eur Heart J"},{"key":"2244_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342:145\u2013153","journal-title":"N Engl J Med"},{"key":"2244_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"MA Pfeffer","year":"1992","unstructured":"Pfeffer MA, Braunwald E, Moy\u00e9 LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC et al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327:669\u2013677","journal-title":"N Engl J Med"},{"key":"2244_CR8","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa032292","volume":"349","author":"MA Pfeffer","year":"2003","unstructured":"Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, K\u00f8ber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM (2003) Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349:1893\u20131906","journal-title":"N Engl J Med"},{"key":"2244_CR9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/eurheartj\/ehr400","volume":"33","author":"FA McAlister","year":"2012","unstructured":"McAlister FA (2012) Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials. Eur Heart J 33:505\u2013514","journal-title":"Eur Heart J"},{"key":"2244_CR10","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jacc.2005.09.055","volume":"47","author":"J McMurray","year":"2006","unstructured":"McMurray J, Solomon S, Pieper K, Reed S, Rouleau J, Velazquez E, White H, Howlett J, Swedberg K, Maggioni A, K\u00f8ber L, Van de Werf F, Califf R, Pfeffer M (2006) The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). J Am Coll Cardiol 47:726\u2013733","journal-title":"J Am Coll Cardiol"},{"key":"2244_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0895-7061(99)00042-4","volume":"12","author":"C Borghi","year":"1999","unstructured":"Borghi C, Bacchelli S, Esposti DD, Bignamini A, Magnani B, Ambrosioni E (1999) Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of myocardial infarction long-term evaluation. Am J Hypertens 12:665\u2013672","journal-title":"Am J Hypertens"},{"key":"2244_CR12","first-page":"793","volume":"15","author":"F Gustafsson","year":"1997","unstructured":"Gustafsson F, Torp-Pedersen C, K\u00f8ber L, Hildebrandt P (1997) Effect of angiotensin converting enzyme inhibition after acute myocardial infarction in patients with arterial hypertension. TRACE study group. Trandolapril Cardiac Event J Hypertens 15:793\u2013798","journal-title":"Trandolapril Cardiac Event J Hypertens"},{"key":"2244_CR13","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937\u2013952","journal-title":"Lancet"},{"key":"2244_CR14","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/jama.2011.250","volume":"305","author":"AM Thompson","year":"2011","unstructured":"Thompson AM, Hu T, Eshelbrenner CL, Reynolds K, He J, Bazzano LA (2011) Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis. JAMA 305:913\u2013922","journal-title":"JAMA"},{"key":"2244_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijcard.2017.08.030","volume":"249","author":"SY Choi","year":"2017","unstructured":"Choi SY, Choi BG, Rha SW, Byun JK, Shim MS, Li H, Mashaly A, Choi CU, Park CG, Seo HS, Oh DJ, Jeong MH (2017) Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers in acute ST-segment elevation myocardial infarction patients with diabetes mellitus undergoing percutaneous coronary intervention. Int J Cardiol 249:48\u201354","journal-title":"Int J Cardiol"},{"key":"2244_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.atherosclerosis.2018.08.038","volume":"277","author":"JK Byun","year":"2018","unstructured":"Byun JK, Choi BG, Rha SW, Choi SY, Jeong MH (2018) Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and non-ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention. Atherosclerosis 277:130\u2013135","journal-title":"Atherosclerosis"},{"key":"2244_CR17","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/bmj.326.7399.1137","volume":"326","author":"ED Grech","year":"2003","unstructured":"Grech ED (2003) ABC of interventional cardiology: percutaneous coronary intervention. II: the procedure. BMJ 326:1137\u20131140","journal-title":"BMJ"},{"key":"2244_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jacc.2012.11.018","volume":"61","author":"PT O'Gara","year":"2013","unstructured":"O\u2019Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX (2013) 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61:485\u2013510","journal-title":"J Am Coll Cardiol"},{"key":"2244_CR19","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1016\/j.jacc.2011.02.011","volume":"57","author":"RS Wright","year":"2011","unstructured":"Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Zidar JP (2011) 2011 ACCF\/AHA focused update incorporated into the ACC\/AHA 2007 guidelines for the management of patients with unstable angina\/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol 57:e215-367","journal-title":"J Am Coll Cardiol"},{"key":"2244_CR20","doi-asserted-by":"publisher","first-page":"183.e11","DOI":"10.1016\/j.amjmed.2009.06.032","volume":"123","author":"DS Tseng","year":"2010","unstructured":"Tseng DS, Kwong J, Rezvani F, Coates AO (2010) Angiotensin-converting enzyme-related cough among Chinese-Americans. Am J Med 123:183.e11\u201315","journal-title":"Am J Med"},{"key":"2244_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjcard.2014.03.055","volume":"114","author":"M Hara","year":"2014","unstructured":"Hara M, Sakata Y, Nakatani D, Suna S, Usami M, Matsumoto S, Sugitani T, Nishino M, Sato H, Kitamura T, Nanto S, Hamasaki T, Hori M, Komuro I (2014) Comparison of 5-year survival after acute myocardial infarction using angiotensin-converting enzyme inhibitor versus angiotensin II receptor blocker. Am J Cardiol 114:1\u20138","journal-title":"Am J Cardiol"},{"key":"2244_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242314","volume":"15","author":"AY Her","year":"2020","unstructured":"Her AY, Choi BG, Rha SW, Kim YH, Choi CU, Jeong MH (2020) The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension. PLoS ONE 15:e0242314","journal-title":"PLoS ONE"},{"key":"2244_CR23","first-page":"22","volume":"41","author":"DE Bloom","year":"2011","unstructured":"Bloom DE, Boersch-Supan A, McGee P, Seike A (2011) Population aging: facts, challenges, and responses. Benefits Compens Int 41:22","journal-title":"Benefits Compens Int"},{"key":"2244_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ddmec.2007.12.006","volume":"4","author":"BA French","year":"2007","unstructured":"French BA, Kramer CM (2007) Mechanisms of post-infarct left ventricular remodeling. Drug Discov Today Dis Mech 4:185\u2013196","journal-title":"Drug Discov Today Dis Mech"},{"key":"2244_CR25","first-page":"86","volume":"23","author":"YH Kim","year":"2020","unstructured":"Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y (2020) Comparison of clinical outcomes between angiotensin-converting-enzyme inhibitors and ARBs in patients with acute myocardial infarction with dyslipidemia after a successful stent implantation. Anatol J Cardiol 23:86\u201398","journal-title":"Anatol J Cardiol"},{"key":"2244_CR26","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1161\/CIRCULATIONAHA.105.594986","volume":"114","author":"MH Strauss","year":"2006","unstructured":"Strauss MH, Hall AS (2006) Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox. Circulation 114:838\u2013854","journal-title":"Circulation"},{"key":"2244_CR27","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","volume":"362","author":"KM Fox","year":"2003","unstructured":"Fox KM (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362:782\u2013788","journal-title":"Lancet"},{"key":"2244_CR28","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1056\/NEJMoa041905","volume":"351","author":"EO McFalls","year":"2004","unstructured":"McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, Pierpont G, Santilli S, Rapp J, Hattler B, Shunk K, Jaenicke C, Thottapurathu L, Ellis N, Reda DJ, Henderson WG (2004) Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351:2795\u20132804","journal-title":"N Engl J Med"},{"key":"2244_CR29","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJM200503033520919","volume":"352","author":"S Yusuf","year":"2005","unstructured":"Yusuf S, Pogue J (2005) ACE inhibition in stable coronary artery disease. N Engl J Med 352:937\u2013939","journal-title":"N Engl J Med"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-023-02244-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-023-02244-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-023-02244-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T12:03:33Z","timestamp":1684929813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-023-02244-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["2244"],"URL":"https:\/\/doi.org\/10.1007\/s00380-023-02244-x","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"assertion":[{"value":"28 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no relationships that could be construed as a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}